BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7923458)

  • 1. A comparison of nifedipine with methyldopa in pregnancy induced hypertension.
    Jayawardana J; Lekamge N
    Ceylon Med J; 1994 Jun; 39(2):87-90. PubMed ID: 7923458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of acebutolol with methyldopa in hypertensive pregnancy.
    Williams ER; Morrissey JR
    Pharmatherapeutica; 1983; 3(7):487-91. PubMed ID: 6669592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension.
    Oumachigui A; Verghese M; Balachander J
    Indian Heart J; 1992; 44(1):39-41. PubMed ID: 1398694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
    Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
    Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
    Paran E; Holzberg G; Mazor M; Zmora E; Insler V
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension.
    Griffis KR; Martin JN; Palmer SM; Martin RW; Morrison JC
    Am J Perinatol; 1989 Oct; 6(4):437-41. PubMed ID: 2789542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy.
    Horvath JS; Phippard A; Korda A; Henderson-Smart DJ; Child A; Tiller DJ
    Obstet Gynecol; 1985 Nov; 66(5):634-8. PubMed ID: 3903581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure, plasma renin activity and calcium metabolism in hypertensive pregnancy: the effect of nifedipine.
    Manninen AK; Tuimala R; Vapaatalo H
    Int J Clin Pharmacol Res; 1990; 10(6):331-7. PubMed ID: 2099358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of alphamethyldopa during the pregnancy-puerperium cycle in hypertensive patients and evaluation of their offspring up to their 3rd year of life].
    De Andrade J
    Arq Bras Cardiol; 1990 Aug; 55(2):137-9. PubMed ID: 2073176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of nifedipine as first-line hypotensive therapy in gestational hypertension.
    Caruso A; Ferrazzani S; De Carolis S; Romano D; Mancinelli S; De Carolis MP
    Minerva Ginecol; 1994 May; 46(5):279-84. PubMed ID: 7936378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day.
    Rodríguez-Roa E; Octavio A; Mayorca E; Castro P; Miranda R; Valecillo E; González M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S151-5. PubMed ID: 11986915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth weight and 24-hour ambulatory blood pressure in nonproteinuric hypertensive pregnancy.
    Waugh J; Perry IJ; Halligan AW; De Swiet M; Lambert PC; Penny JA; Taylor DJ; Jones DR; Shennan A
    Am J Obstet Gynecol; 2000 Sep; 183(3):633-7. PubMed ID: 10992185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nifedipine and methyldopa on maternal cerebral circulation.
    Serra-Serra V; Kyle PM; Chandran R; Redman CW
    Br J Obstet Gynaecol; 1997 May; 104(5):532-7. PubMed ID: 9166192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension.
    Rudnicki M; Frølich A; Pilsgaard K; Nyrnberg L; Møller M; Sanchez M; Fischer-Rasmussen W
    Gynecol Obstet Invest; 2000; 49(4):231-5. PubMed ID: 10828704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.